- Home
- LENZ vs MLKN Comparison
LENZ vs MLKN Comparison
Compare LENZ & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- MLKN
- Stock Information
- Founded
- LENZ 2019
- MLKN 1905
- Country
- LENZ United States
- MLKN United States
- Employees
- LENZ N/A
- MLKN N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- MLKN Office Equipment/Supplies/Services
- Sector
- LENZ Health Care
- MLKN Consumer Discretionary
- Exchange
- LENZ Nasdaq
- MLKN Nasdaq
- Market Cap
- LENZ 1.1B
- MLKN 1.2B
- IPO Year
- LENZ 2021
- MLKN N/A
- Fundamental
- Price
- LENZ $41.98
- MLKN $21.44
- Analyst Decision
- LENZ Strong Buy
- MLKN
- Analyst Count
- LENZ 4
- MLKN 0
- Target Price
- LENZ $49.75
- MLKN N/A
- AVG Volume (30 Days)
- LENZ 706.3K
- MLKN 364.9K
- Earning Date
- LENZ 11-05-2025
- MLKN 09-23-2025
- Dividend Yield
- LENZ N/A
- MLKN 3.50%
- EPS Growth
- LENZ N/A
- MLKN N/A
- EPS
- LENZ N/A
- MLKN N/A
- Revenue
- LENZ $5,000,000.00
- MLKN $3,669,900,000.00
- Revenue This Year
- LENZ N/A
- MLKN $4.74
- Revenue Next Year
- LENZ $258.37
- MLKN $3.64
- P/E Ratio
- LENZ N/A
- MLKN N/A
- Revenue Growth
- LENZ N/A
- MLKN 1.14
- 52 Week Low
- LENZ $16.54
- MLKN $15.25
- 52 Week High
- LENZ $42.08
- MLKN $28.33
- Technical
- Relative Strength Index (RSI)
- LENZ 66.44
- MLKN 56.83
- Support Level
- LENZ $36.81
- MLKN $20.37
- Resistance Level
- LENZ $40.35
- MLKN $21.76
- Average True Range (ATR)
- LENZ 1.84
- MLKN 0.60
- MACD
- LENZ 0.04
- MLKN -0.09
- Stochastic Oscillator
- LENZ 98.27
- MLKN 57.53
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.